M

Malcolm K. Brenner

Houston Methodist

ORCID: 0000-0002-3657-7675

Publishes on CAR-T cell therapy research, Virus-based gene therapy research, Immune Cell Function and Interaction. 881 papers and 54k citations.

PubIndex Score98Top 2%How it's scored

881Publications

54kTotal Citations

First publication: 1981First senior author: 1983

CAR-T cell therapy research Virus-based gene therapy research Immune Cell Function and Interaction Immunotherapy and Immune Responses Hematopoietic Stem Cell Transplantation

Top publicationsby citations

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease

Catherine M. Bollard, Helen E. Heslop, Dagmar Dilloo et al.|The Journal of Experimental Medicine|2004

Cited by 390

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade

Tessa Gargett, Michael P. Brown, Wenbo Yu et al.|Molecular Therapy|2016

Cited by 358

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Benjamin Musher, Angelica Loskog, Eric K. Rowinsky et al.|The Lancet Oncology|2024

Cited by 64

A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer.

Benjamin Musher, Angelica Sara Ingrid Loskog, Brandon G. Smaglo et al.|Journal of Clinical Oncology|2022

Cited by 19

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors.

Robert A. Krance, Malcolm K. Brenner, Helen E. Heslop et al.|PubMed|1993

Cited by 12